GSK's drive to resurrect its multiple myeloma therapy Blenrep has continued with new data from the DREAMM-7 trial showing an ...

Despite significant medical advancements in the oncology space, 30% of patients in the GSK/Harris Poll survey said they never ...

Since Politico reported on the potential selection Thursday afternoon, Pfizer and GSK shares are down about 5% ... against ...

Leerink Partners analyst Daina Graybosch has maintained their bullish stance on ITOS stock, giving a Buy rating on November 12. Daina ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Researchers at Washington University School of Medicine in St. Louis have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer’s genesis and ...

GSK is a global biopharmaceutical company headquartered in Brentford ... durable protection and has a favorable efficacy and safety profile for up to three seasons. This essentially makes Arexvy ...

A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence ...

Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its ... his "Make America Healthy Again" agenda. Erica Kollmann GSK's Q3 Earnings Hit By Lower Than Expected Vaccine Sales, Cautions ...

The Q3 presentation was sent to our distribution list by e-mail and you can also find it on gsk.com. Please turn to ... removing a clear perceived risk for the company and allowing us to focus ...

Under his leadership, the North office was responsible for numerous global and Indian brands like, PepsiCo, Nestle, GSK ...

Head-to-head clinical results indicate a potential best-in-class combined efficacy & safety profile of non-adjuvanted bivalent RSV vaccine candidate (SCB-1019) -- ...